Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock

被引:7
作者
Giacometti, A
Cirioni, O
Ghiselli, R
Mocchegiani, F
Paggi, AM
Orlando, F
Kamysz, W
Kasprzykowski, F
Mackiewicz, Z
Scalise, G
Saba, V
机构
[1] Univ Ancona, Inst Infect Dis & Publ Hlth, Ancona, Italy
[2] Univ Ancona, INRCA IRRCS, Dept Gen Surg 1, Ancona, Italy
[3] INRCA IRRCS, Dept Res, Ctr Biotechnol, Ancona, Italy
[4] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland
关键词
D O I
10.1093/jac/49.1.193
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The efficacy of two polymyxin-like peptides, KFFKFFKFF and IKFLKFLKFL, alone and combined with levofloxacin, was investigated in a rat model of septic shock. Rats were given an ip injection of 2 x 10(10) cfu of Escherichia coli and randomized to receive ip isotonic sodium chloride solution, 7 mg/kg levofloxacin, 1 mg/kg polymyxin B and 1 mg/kg of each polymyxin-like peptides alone or combined with 7 mg/kg levofloxacin. Polymyxins achieved a significant reduction in plasma endotoxin and tumour necrosis factor alpha (TNF-alpha) concentration. Levofloxacin significantly reduced the bacterial growth and TNF-alpha concentration. The combinations of polymyxin-like peptides and levofloxacin demonstrated the highest efficacy.
引用
收藏
页码:193 / 196
页数:4
相关论文
共 9 条
[1]  
Abraham E, 1998, LANCET, V351, P929
[2]   E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial [J].
Angus, DC ;
Birmingham, MC ;
Balk, RA ;
Scannon, PJ ;
Collins, D ;
Kruse, JA ;
Graham, DR ;
Dedhia, HV ;
Homann, S ;
MacIntyre, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13) :1723-1730
[3]   GRAM-NEGATIVE SEPSIS - A DILEMMA OF MODERN MEDICINE [J].
BONE, RC .
CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (01) :57-68
[4]   PURIFICATION, TOXICITY, AND ANTIENDOTOXIN ACTIVITY OF POLYMYXIN-B NONAPEPTIDE [J].
DANNER, RL ;
JOINER, KA ;
RUBIN, M ;
PATTERSON, WH ;
JOHNSON, N ;
AYERS, KM ;
PARRILLO, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1428-1434
[5]   Effect of trovafloxacin on production of cytokines by human monocytes [J].
Khan, AA ;
Slifer, TR ;
Remington, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1713-1717
[6]   Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality -: A multicenter study [J].
Mira, JP ;
Cariou, A ;
Grall, F ;
Delclaux, C ;
Losser, MR ;
Heshmati, F ;
Cheval, C ;
Monchi, M ;
Teboul, JL ;
Riché, F ;
Leleu, G ;
Arbibe, L ;
Mignon, A ;
Delpech, M ;
Dhainaut, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (06) :561-568
[7]   CLINICAL RELEVANCE OF ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE [J].
PRINS, JM ;
VANDEVENTER, SJH ;
KUIJPER, EJ ;
SPEELMAN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1211-1218
[8]   Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria [J].
Vaara, M ;
Porro, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1801-1805
[9]   Treating patients with severe sepsis [J].
Wheeler, AP ;
Bernard, GR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (03) :207-214